204 related articles for article (PubMed ID: 20211890)
1. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
Nannini EC; Stryjewski ME; Singh KV; Rude TH; Corey GR; Fowler VG; Murray BE
Antimicrob Agents Chemother; 2010 May; 54(5):2206-8. PubMed ID: 20211890
[TBL] [Abstract][Full Text] [Related]
2. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses.
Bremmer DN; Balada-Llasat JM; Goff DA; Bauer KA
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):192-194. PubMed ID: 28291629
[TBL] [Abstract][Full Text] [Related]
4. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
5. Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees.
Yun HC; Ellis MW; Jorgensen JH
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):463-6. PubMed ID: 17911001
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
Pillar CM; Aranza MK; Shah D; Sahm DF
J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
[TBL] [Abstract][Full Text] [Related]
7. Comparative sensitivity of penicillinase producing Staphylococcus aureus to four cephalosporin antibiotics.
Bremner DA; Fortune J
N Z Med J; 1975 Sep; 82(548):189-90. PubMed ID: 1059959
[TBL] [Abstract][Full Text] [Related]
8. Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Lemaire S; Glupczynski Y; Duval V; Joris B; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2009 Jun; 53(6):2289-97. PubMed ID: 19289525
[TBL] [Abstract][Full Text] [Related]
9. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
Menzies RE; Cornere BM; MacCulloch D
Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
[TBL] [Abstract][Full Text] [Related]
10. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
Hansen-Nord M; Gahrn-Hansen B; Siboni K
APMIS; 1988 Feb; 96(2):133-40. PubMed ID: 3345258
[TBL] [Abstract][Full Text] [Related]
11. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
[TBL] [Abstract][Full Text] [Related]
15. Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.
Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
Antimicrob Agents Chemother; 1980 May; 17(5):856-60. PubMed ID: 6901595
[TBL] [Abstract][Full Text] [Related]
16. Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.
Sabath LD; Garner C; Wilcox C; Finland M
Antimicrob Agents Chemother; 1975 Sep; 8(3):344-9. PubMed ID: 1167043
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
19. Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis.
Lin G; Appelbaum PC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):233-5. PubMed ID: 17997257
[TBL] [Abstract][Full Text] [Related]
20. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
Vouillamoz J; Entenza JM; Hohl P; Moreillon P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
